+987.9%
MRNA vs STLA
-53.0%
+1,040.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | STLA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +3.8% | +9.3% | +10.3% |
| 7D | +20.6% | -0.6% | +21.3% | +21.1% |
| 30D | +27.1% | +3.6% | +23.6% | +22.3% |
| 3M | +353.4% | -20.6% | +374.0% | +411.5% |
| 6M | +446.3% | -34.3% | +480.6% | +542.6% |
| YTD | +776.2% | -57.3% | +833.5% | +1,012.9% |
| 1Y | +987.9% | -52.6% | +1,040.6% | +1,149.7% |
| All | +987.9% | -53.0% | +1,040.9% | +1,149.7% |
Cumulative growth
Daily Returns
Daily percentage return beside STLA.
Daily Out/Under-Performance
Portfolio return minus STLA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STLA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded STLA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling